Improving health outcomes for infants

Article
Article
Improving Health Outcomes for Infants
A longer shelf life for household staples
 
 
 
E_SDG goals_icons-individual-rgb-03.png

E_SDG goals_icons-individual-rgb-17.png

 
 
 

Sepsis continues to be a leading cause of newborn deaths globally, and infants in developing countries are disproportionately impacted. Altogether, nearly three million newborns and 1.2 million additional children suffer from sepsis every year, according to the World Health Organization, yet there’s no consensus on how to prevent sepsis effectively.

The Centre for Global Child Health at The Hospital for Sick Children (SickKids) in Toronto has selected DuPont Nutrition & Biosciences to provide probiotics and prebiotics (fiber) for a new, large-scale research study focusing on the microbiome and severe infections in infants in Bangladesh. Funded by a grant from the Bill & Melinda Gates Foundation, the research will be conducted in collaboration with the International Centre for Diarrheal Disease Research and the Child Health Research Foundation, both based in Dhaka, Bangladesh.

DuPont scientists will offer their expertise to help determine whether a precise probiotic-prebiotic combination can effectively colonize an infant’s developing microbiome, reduce the incidence of sepsis, and improving other health outcomes in early life.

 

 https://www.who.int/news-room/fact-sheets/detail/sepsis

 https://www.dupontnutritionandbiosciences.com/news/probiotics-international-pediatric-sepsis-research.html

 
 
 
 
 
 
 
 
 
 
 
 

More information on this story:

More in Sustainability
Community Impact
Community Impact
Sustainability Reporting
Sustainability Reporting
Position Statements
Position Statements
Product Stewardship
Product Stewardship